GlassScriptPhysician profile
Michelle R Devera
NPI 1952306557
$1,705.42
in general payments reported to CMS, 2019-2025
19 companies · $87.17 in 2025
The $87.17 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $269 · 2021: $656 · 2022: $25.08 · 2025: $87.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $87.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $87.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $560.66 | 2019-2021 | |
| Therapeuticsmd, INC. | $277.46 | 2019-2022 | |
| Pfizer INC. | $105.79 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $100.57 | 2019 | |
| Merck Sharp & Dohme LLC | $94.57 | 2020-2021 | |
| Masimo Corporation | $87.17 | 2025 | Sedline |
| Hologic Sales and Service, LLC | $70.23 | 2020-2021 | |
| Agile Therapeutics, INC. | $69.01 | 2021 | |
| Amgen INC. | $59.60 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.74 | 2019-2020 | |
| Meditrina | $40.70 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $31.07 | 2021 | |
| Vertical Pharmaceuticals, LLC | $28.67 | 2019 | |
| Lupin INC. | $27.20 | 2019-2020 | |
| Duchesnay USA Incorporated | $26.13 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $23.08 | 2021 | |
| Boston Scientific Corporation | $18.82 | 2019 | |
| Exeltis, USA INC. | $18.26 | 2020 | |
| Glaxosmithkline, LLC. | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Devera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.